EUVIMEDEUVIMED entdecken
Mixed-Methods-StudieOpen Access · CC BY 4.0

A Framework for Ethical and Clinical Governance Evaluation of Innovative Medicines in Children: A Mixed Methods Study

Sonya Stacey iD, Jamie Lam, Fiona Gregory, Shakira Wild, Steven McTaggart, Helen Irving

Journal of Paediatrics and Child Health · 2026

DOI: 10.1111/jpc.70501 ↗

Kurz gefasst

Mixed-Methods-Studie in der Zeitschrift Journal of Paediatrics and Child Health, 2026. Verfasst von Sonya Stacey und 5 weiteren Autor:innen. Beteiligte Einrichtung: Queensland Children's Hospital, South Brisbane, Australia. Hauptthemen laut MEDLINE: Clinical Governance, Pediatrics, Drugs, Investigational. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The aim of this project was to develop and implement a working definition and ethical framework for use of innovative medicine in contemporary Australian paediatric practice.

Methods

A mixed methods research methodology was undertaken using a Delphi process to establish a definition of innovative medicines in paediatric patients. This definition was used to quantitate innovative medicines use in a retrospective quantitative review of non‐formulary medications in a tertiary paediatric hospital. An existing ethical framework from the United Kingdom was adapted to supplement standard clinical governance processes in contemporary Australian paediatric practice.

Results

A definition of innovative medicines and an ethical framework for their use in paediatric patients was developed after four rounds of feedback from 18 Australian paediatric experts. A total of 2906 individual patient medication approval applications were reviewed, 1447 of these were included for analysis, 120 of which were for medications not on the Australian Register of Therapeutic Goods and six applications were considered innovative using the newly developed definition.

Conclusions

Evaluation of the use of innovative medicines in paediatric patients is essential to ensure patient safety and critical clinical governance of medication use. An adapted ethical framework for Australian practice is a valuable tool to assist clinical governance processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical GovernancePediatricsDrugs, InvestigationalHumansAustraliaChildRetrospective StudiesDelphi TechniqueHospitals, Pediatric

Substanzen

Drugs, Investigational

Autor:innen und Institutionen

  • Queensland Children's Hospital, South Brisbane, Australia.
  • The University of Queensland, St Lucia, Australia.

ORCID-Profile: Sonya Stacey

Zitieren

APA

Stacey, S., Lam, J., Gregory, F., Wild, S., McTaggart, S., & Irving, H. (2026). A Framework for Ethical and Clinical Governance Evaluation of Innovative Medicines in Children: A Mixed Methods Study. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.70501

Vancouver

Stacey S, Lam J, Gregory F, Wild S, McTaggart S, Irving H. A Framework for Ethical and Clinical Governance Evaluation of Innovative Medicines in Children: A Mixed Methods Study. Journal of Paediatrics and Child Health. 2026. doi:10.1111/jpc.70501

BibTeX
@article{Stacey2026,
  author = {Stacey, Sonya and Lam, Jamie and Gregory, Fiona and Wild, Shakira and McTaggart, Steven and Irving, Helen},
  title = {A Framework for Ethical and Clinical Governance Evaluation of Innovative Medicines in Children: A Mixed Methods Study},
  journal = {Journal of Paediatrics and Child Health},
  year = {2026},
  doi = {10.1111/jpc.70501}
}
Kostenlos starten →